m6A-related GRK5 was downregulated expression in BC and linked to unfavorable prognosis, therefore, we hypothesized downregulated GRK5 chiefly hampered the infiltration of CD8 + T cells, CD4 + T cells and Dendritic cells to attenuate the response of antitumor. The gene discussed is CD4; the disease is breast cancer.